Top

01-01-2015 | Renal cell carcinoma | Article

9. Surgical Approaches to Early-Stage Renal Cell Carcinoma

Authors: Daniel J. Canter, MD, David B. Cahn, DO, Robert G. Uzzo, MD

Publisher: Springer International Publishing

Abstract

With the increased use of cross-sectional imaging, the incidence of early-stage localized renal cell carcinoma (RCC) or the small renal mass continues to rise. Treatment options for localized RCC include surgical excision, ablative techniques, and active surveillance. All treatment paradigms have excellent short-term, intermediate-term, long-term, and, when available, oncologic outcomes. Each technique offers various advantages and disadvantages compared to the other treatment alternatives. Due to the success of the various treatment approaches, the decision to treat a particular patient with localized RCC in a certain manner is relatively subjective and based on practitioner and patient biases. Considering recent data that has questioned the utility of active intervention for localized RCC, especially in the elderly, attempts have been made to quantify the risk/benefit of treatment. Also, reproducible measures of renal tumor anatomy and the refinement of the measurement of renal function have been created and advocated to more accurately assess the oncologic risk of localized RCC against the risks of treatment-related adverse events and chronic kidney disease. In this chapter, we review the existing treatment options for localized RCC contextualized against the risks of competing health comorbidities and chronic kidney disease. Furthermore, we discuss the utility of reproducible, objective methods to preoperatively define salient renal mass anatomy and how this can potentially objectify treatment decision making. Finally, in this chapter, we attempt to provide a standardized platform whereby the treatment decision-making process for localized RCC accounts for all the available objective data in order to arrive at the optimal treatment decision for each individual patient based on the risks and benefits of treatment.

Chow WH, Devesa SS, Warren JL et al (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631PubMedCrossRef

Hollingsworth JM, Miller DC, Daignault S et al (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98:1331–1334PubMedCrossRef

American Cancer Society (2014) Cancer facts and figures 2014. American Cancer Society, Atlanta

Motzer RJ, Jonasch E, Agarwal N et al (2014) NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw 12:175–182PubMed

Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279PubMedCrossRef

Parsons JK, Schoenberg MS, Carter HB (2001) Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology 57:1013–1015PubMedCrossRef

Mckiernan J, Yossepowitch O, Kattan MW et al (2002) Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 60:1003–1009PubMedCrossRef

Kutikov A, Fossett LK, Ramchandani P et al (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68:737–740PubMedCrossRef

Lane BR, Poggio ED, Herts BR et al (2009) Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol 182:435–443; discussion 443–444PubMedCrossRef

10.

Lane BR, Demirjian S, Weight CJ et al (2010) Performance of the chronic kidney disease-epidemiology study equations for estimating glomerular filtration rate before and after nephrectomy. J Urol 183:896–901PubMedCrossRef

11.

Canter D, Kutikov A, Sirohi M et al (2011) Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology 77:781–785PubMedCentralPubMedCrossRef

12.

Frank I, Blute ML, Cheville JC et al (2003) Solid renal tumors: an analysis of pathologic features related to tumor size. J Urol 170:2217–2220PubMedCrossRef

13.

Volpe A, Gill IS, Uzzo RG et al (2012) Rationale for percutaneous biopsy and histologic characterisation of renal tumors. Eur Urol 62:505–506CrossRef

14.

Chawla SN, Crispen PL, Hanlon AL et al (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175:425–431PubMedCrossRef

15.

Kinsella K, Velkoff VA (2001) An aging world [series py5/O1-1]. U.S. Census Bureau (Government Printing Office), Washington, DC

16.

Yancik R, Ries LA (2004) Cancer in older persons: an international issue in an aging world. Semin Oncol 31:128–136PubMedCrossRef

17.

Piccirillo JF, Tierney RM, Costas I et al (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441–2447PubMedCrossRef

18.

de Groot V, Beckerman H, Lankhorst GJ et al (2003) How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 56:221–229PubMedCrossRef

19.

Rozzini R, Sabatini T, Barbisoni P et al (2004) How to measure comorbidity in elderly persons. J Clin Epidemiol 57:321–322PubMedCrossRef

20.

Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef

21.

Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156PubMedCrossRef

22.

Revening LM, Canter DJ, Taylor MD et al (2013) Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. J Am Coll Surg 217:665–670CrossRef

23.

Hanrahan EO, Gonzalez-Angulo AM, Giordano SH et al (2007) Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma. J Clin Oncol 25:4952–4960PubMedCrossRef

24.

Mell LK, Dignam JJ, Salama JK et al (2010) Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28:15–20PubMedCrossRef

25.

Santos Arrontes D, Fernandez Acenero MJ, Garcia Gonzalez JI et al (2008) Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index. J Urol 179:857–861PubMedCrossRef

26.

Hollingsworth JM, Miller DC, Daignault S et al (2007) Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 109:1763–1768PubMedCrossRef

27.

Kutikov A, Egleston BL, Wong YN et al (2010) Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 28:311–317PubMedCentralPubMedCrossRef

28.

Kutikov A, Canter D, Uzzo RG et al (2012) Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol 188:2077–2083PubMedCrossRef

29.

Smaldone MC, Kutikov A, Egleston BL et al (2012) Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118:997–1006PubMedCentralPubMedCrossRef

30.

Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853PubMedCrossRef

31.

Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786–793PubMedCrossRef

32.

Simmons MN, Ching CB, Samplaski MK et al (2010) Kidney tumor location measurement using the C index method. J Urol 183:1708–1713PubMedCrossRef

33.

Cha E, Jeun B, Casey N et al (2010) Identification of nephrometric variables predictive of renal impairment following partial nephrectomy. J Urol 183:e205CrossRef

34.

Hayn M, Schwaab T, Underwood W et al (2010) Application of R.E.N.A.L. nephrometry score to laparoscopic partial nephrectomy. J Urol 183:e245CrossRef

35.

Khemees TA, Yuh BJ, Stacey A et al (2010) Postoperative morbidity of robotic versus open partial nephrectomy: the impact of preoperative tumor characteristics. J Urol 183:e386CrossRef

36.

Tomaszewski JJ, Smaldone MC, Uzzo RG et al (2014) Anatomic complexity quantitated by nephrometry score is associated with prolonged warm ischemia time during robotic partial nephrectomy. Urology 84:340–344PubMedCrossRef

37.

Hafez KS, Novick AC, Butler BP (1998) Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol 159:1156–1160PubMedCrossRef

38.

Kutikov A, Manley BJ, Canter D et al (2010) Anatomical features of enhancing renal masses predict histology and grade–an analysis using nephrometry. J Urol 183(4):e479CrossRef

39.

Novick AC, Streem S, Montie JE et al (1989) Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol 141:835–839PubMed

40.

Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol 163:442–445PubMedCrossRef

41.

Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166:6–18PubMedCrossRef

42.

Thompson RH, Siddiqui S, Lohse CM et al (2009) Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 182:2601–2606PubMedCentralPubMedCrossRef

43.

Dulabon LM, Lowrance WT, Russo P et al (2010) Trends in renal tumor surgery delivery within the United States. Cancer 116:2316–2321PubMedCentralPubMed

44.

Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047PubMedCrossRef

45.

McKiernan J, Simmons R, Katz J et al (2002) Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59:816–820PubMedCrossRef

46.

Huang WC, Levey AS, Serio AM et al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735–740PubMedCentralPubMedCrossRef

47.

Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRef

48.

Letourneau I, Ouimet D, Dumont M et al (2003) Renal replacement in end-stage renal disease patients over 75 years old. Am J Nephrol 23:71–77PubMedCrossRef

49.

Cooperberg MR, Kane CJ, Mallin K et al (2009) National trends in treatment of stage I renal cell carcinoma. J Urol 181:319 (abstract)CrossRef

50.

Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297–301PubMed

51.

Giuliani L, Giberti C, Martorana G et al (1990) Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 143:468–473; discussion 473–474PubMed

52.

Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323PubMedCrossRef

53.

Thompson RH, Boorjian SA, Lohse CM et al (2008) Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179:468–471; discussion 472–473PubMedCrossRef

54.

Huang WC, Elkin EB, Levey AS et al (2009) Partial nephrectomy versus radical nephrectomy in patients with small renal tumors–is there a difference in mortality and cardiovascular outcomes? J Urol 181:55–61; discussion 61–62PubMedCentralPubMedCrossRef

55.

Lesage K, Joniau S, Fransis K et al (2007) Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur Urol 51:614–620PubMedCrossRef

56.

Uzzo RG, Wei JT, Hafez K et al (1999) Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma. Urology 54:994–998PubMedCrossRef

57.

Van Poppel H, Da Pozzo L, Albrecht W et al (2007) A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 51:1606–1615PubMedCrossRef

58.

Patard JJ, Pantuck AJ, Crepel M et al (2007) Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol 52:148–154PubMedCrossRef

59.

Hansen J, Sun M, Bianchi M et al (2012) Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology 80:347–353PubMedCrossRef

60.

Breau RH et al (2010) Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol 183:903–908PubMedCrossRef

61.

Long CA, Canter DJ, Kutikov A et al (2012) Partial nephrectomy for renal masses > 7cm: technical, oncological and functional outcomes. BJU Int 109:1450–1456PubMedCrossRef

62.

Berger A, Brandina R, Atalla MA et al (2009) Laparoscopic radical nephrectomy for renal cell carcinoma: oncological outcomes at 10 years or more. J Urol 182:2172–2176PubMedCrossRef

63.

Tsui KH, Shvarts O, Smith RB et al (2000) Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 163:1090–1095PubMedCrossRef

64.

Permpongkosol S, Chan DY, Link RE et al (2005) Long-term survival analysis after laparoscopic radical nephrectomy. J Urol 174:1222–1225PubMedCrossRef

66.

Colombo JR Jr, Haber GP, Jelovsek JE et al (2008) Seven years after laparoscopic radical nephrectomy: oncologic and renal functional outcomes. Urology 71:1149–1154PubMedCrossRef

67.

Clayman RV, Kavoussi LR, Soper NJ et al (1991) Laparoscopic nephrectomy: initial case report. J Urol 146:278–282PubMed

68.

Desai MM, Gill IS, Ramani AP et al (2003) Laparoscopic radical nephrectomy for cancer with level I renal vein involvement. J Urol 169:487–491PubMedCrossRef

69.

Guzzo TJ, Schaeffer EM, McNeil BK et al (2009) Laparoscopic radical nephrectomy for patients with pathologic T3b renal-cell carcinoma: the Johns Hopkins experience. J Endourol 23:63–67PubMedCrossRef

70.

Steinnerd LE, Vardi IY, Bhayani SB (2007) Laparoscopic radical nephrectomy for renal carcinoma with known level I renal vein tumor thrombus. Urology 69:662–665PubMedCrossRef

71.

Gill IS, Kavoussi LR, Lane BR et al (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41–46PubMedCrossRef

72.

Gill IS, Desai MM, Kaouk JH et al (2002) Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J Urol 167:469–7; discussion 475–476PubMedCrossRef

73.

Haber GP, White WM, Crouzet S et al (2010) Robotic versus laparoscopic partial nephrectomy: single-surgeon matched cohort study of 150 patients. Urology 76:754–758PubMedCrossRef

74.

Wang AJ, Bhayani SB (2009) Robotic partial nephrectomy versus laparoscopic partial nephrectomy for renal cell carcinoma: single-surgeon analysis of >100 consecutive procedures. Urology 73:306–310PubMedCrossRef

75.

Ho H, Schwentner C, Neururer R et al (2009) Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int 103:663–668PubMedCrossRef

76.

Benway BM, Bhayani SB, Rogers CG et al (2009) Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J Urol 182:866–872PubMedCrossRef

77.

Scoll BJ, Uzzo RG, Chen DY et al (2010) Robot-assisted partial nephrectomy: a large single-institutional experience. Urology 75:1328–1334PubMedCentralPubMedCrossRef

78.

Gaur DD, Agarwal DK, Purohit KC (1993) Retroperitoneal laparoscopic nephrectomy: initial case report. J Urol 149:103–105PubMed

79.

McAllister M, Bhayani SB, Ong A et al (2004) Vena caval transection during retroperitoneoscopic nephrectomy: report of the complication and review of the literature. J Urol 172:183–185PubMedCrossRef

80.

Viterbo R, Greenberg RE, Al-Saleem T et al (2005) Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland. J Urol 174:446–450PubMedCrossRef

81.

Matin SF, Gill IS (2002) Laparoscopic radical nephrectomy: retroperitoneal versus transperitoneal approach. Curr Urol Rep 3:164–171PubMedCrossRef

82.

Chen DY, Uzzo RG (2011) Evaluation and management of the renal mass. Med Clin North Am 95:179–189PubMedCrossRef

83.

Blom JHM, Van Poppel H, Marechal JM et al (2012) Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55:28–34CrossRef

84.

Volpe A, Panzarella T, Rendon RA et al (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745PubMedCrossRef

85.

Hoffmann NE, Bischof JC (2002) The cryobiology of cryosurgical injury. Urology 60:40–49PubMedCrossRef

86.

Aron M, Gill IS (2007) Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy. Eur Urol 51:348–357PubMedCrossRef

87.

Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113:2671–2680PubMedCentralPubMedCrossRef

88.

Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma–a meta-analysis and review. J Urol 179:1227–1233; discussion 1233–1234PubMedCrossRef

89.

Thompson RH, Atwell T, Schmit G et al (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67(2):252–259PubMedCrossRef

90.

Finley DS, Beck S, Box G et al (2008) Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 180:492–498; discussion 498PubMedCrossRef

91.

Long CJ, Kutikov A, Canter DJ et al (2011) Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised? BJU Int 107:1376–1380PubMedCrossRef

92.

Mehrazin R, Smaldone MC, Kutikov A et al (2014) Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol 192:659–664PubMedCrossRef

93.

Donat SM, Diaz M, Bishoff JT et al (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190:407–416PubMedCrossRef

94.

Crispen PL, Viterbo R, Fox EB et al (2008) Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 112:1051–1057PubMedCrossRef

95.

Hollenbeck BK, Taub DA, Miller DC et al (2006) National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67:254–259PubMedCrossRef

» This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

Medicine Matters Oncology

Abstract